RT Journal Article
SR Electronic
A1 Alexander, Lori
T1 Updated Efficacy Results from XELOX1/NO16966, a Randomized Phase 3 Trial in First-Line Metastatic Colorectal Cancer
JF MD Conference Express
YR 2007
FD SAGE Publications
VO 7
IS 3
SP 22
OP 26
DO 10.1177/155989770700700310
UL http://mdc.sagepub.com/content/7/3/22.abstract
AB This article discusses multiple studies using capecitabine plus oxaliplatin (XELOX), 5-fluorouracil (5-FU), leucovorin, and oxaliplatin (FOLFOX-4), and Infusional 5-FU/LV (FOLFOX-6), as well as the the MOSAIC and XELOX-1 Trials for the treatment of metastatic colorectal cancer.